Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. - Test2 - elhamkhani - TriplyDB

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

http://www.wikidata.org/entity/Q27851397

about

The etiologic spectrum of head and neck squamous cell carcinoma in young patients Caffeic Acid phenethyl ester is a potential therapeutic agent for oral cancer Human Papillomavirus (HPV)-associated Oral Cancers and Treatment Strategies Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma Therapeutic insights from genomic studies of head and neck squamous cell carcinomas Tumor antigen-specific monoclonal antibodies and induction of T-cell immunity CIViC database Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.Molecular Aspects of Head and Neck Cancer Therapy Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma Novel insight into mutational landscape of head and neck squamous cell carcinoma Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity.Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.Combination of NTP with cetuximab inhibited invasion/migration of cetuximab-resistant OSCC cells: Involvement of NF-κB signaling.Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas Synthesizer: Expediting synthesis studies from context-free data with information retrieval techniques.Advances in the management of squamous cell carcinoma of the head and neck.Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.Targeting the epidermal growth factor receptor for head and neck cancer chemoprevention The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer.Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck.Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer Homeobox A7 increases cell proliferation by up-regulation of epidermal growth factor receptor expression in human granulosa cells Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer mTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations.Epithelioid sarcoma expresses epidermal growth factor receptor but gene amplification and kinase domain mutations are rare.HPV-associated head and neck cancer: a virus-related cancer epidemic.Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.

P2860

03aeefa8999c3fd7fcf1860716a309a5492238a4

P248

Q26741362-A35B24D5-D500-463E-885E-0A8816D75298 Q26822487-E328034E-CDA6-49CF-AEBC-76F22EC46D3B Q26822621-568C3125-7C5C-4EC9-A6C8-ADD5E2C4636D Q26991953-3CF742BF-AC37-4191-9A66-0D371D646FEF Q27006854-18B4AA4C-5DCC-485A-89E5-4C7D45AF6DBB Q27009908-B7B3E2DC-54AD-483A-A13B-672B1943B8D3 Q27612411-FAE14763-31DD-49AE-A99F-CF947C4767DF Q27851592-50D2655E-D044-4FB0-99EE-0087CEB359C2 Q27853173-4990984F-5E70-4E9F-ABA1-6E6767576003 Q28082815-3731B14C-CB80-4EBB-AE87-F4EB634C1C4E Q28385950-27EA512B-7172-4C7F-BE27-CFBDC7963DBC Q30441193-BCB85AD6-86FA-4A09-A079-22E9184A4637 Q30498197-217043B7-B78C-4976-9EFB-A47E449C0E70 Q31096247-3DC13418-B301-4D86-B2F1-812D84811059 Q31116459-340AD526-9FDA-4D33-AC8C-3C8217BC4A98 Q33434648-BD19DCF7-5056-4D93-AE41-2588102741A8 Q33466722-581EC3D9-A924-4C54-8419-A1AEB40E4357 Q33525226-52606792-2BDA-49FC-9C07-8F93544DFE35 Q33570512-A1F39575-D605-466B-90FF-6AF6DE48480E Q33575439-8C890C92-631F-4581-A881-1D507FEB4F88 Q33596673-C5B8EB56-7F43-4AA5-8933-79108B25B0AE Q33720431-677C37C5-E2B1-43CB-B1F7-A83D3A4564C2 Q33767100-EC6C721C-C318-4E5C-8092-BC74D8713570 Q33770030-D7012949-67F0-4FA5-8892-D6A131BF37A5 Q33875694-7CD56BB2-A690-4362-AE40-0722793E7815 Q33906083-5E13D392-9F4F-48D2-BE82-084F92C2C2C1 Q33916035-0DC5A902-5415-4169-8285-ADBD14300286 Q33924908-D31E530F-8BA7-4A79-B1C1-398EDDE9C622 Q33976619-3EEB9ECD-AF42-46BE-A732-34DAD225E534 Q33986942-8ED661D9-660E-4B58-BD1D-4F1564F2D62F Q33990915-62941F6A-4B00-4622-99F6-43FE85EF69AB Q33998155-D8A8FC00-BCA0-4E7A-B592-510EB3CC279B Q34012333-BD20C802-0D5E-41D3-A7EE-1D31D9EA7342 Q34017668-D9B6207F-ED57-435F-9787-C8AEACC173FC Q34049613-E923A5F1-F2FF-46D0-90FE-3469AAEDB4A3 Q34095970-098E9BFA-2E15-4931-8A93-7303EC1AF818 Q34114152-A56D81D5-F63E-4E23-AFD3-95E22245A235 Q34125003-F3137A82-076F-4441-91ED-5FDCC978E419 Q34160540-599ADCF8-3F55-4C6C-BA8B-9BD631ED7DE4 Q34194706-EB88972A-8BCA-46D7-BADA-07D21700D013

P2860

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

http://www.wikidata.org/entity/Q27851397

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Increased epidermal growth fac ...... neck squamous cell carcinomas.

@ast

Increased epidermal growth fac ...... neck squamous cell carcinomas.

@en

Increased epidermal growth fac ...... neck squamous cell carcinomas.

@nl

type

label

Increased epidermal growth fac ...... neck squamous cell carcinomas.

@ast

Increased epidermal growth fac ...... neck squamous cell carcinomas.

@en

Increased epidermal growth fac ...... neck squamous cell carcinomas.

@nl

prefLabel

Increased epidermal growth fac ...... neck squamous cell carcinomas.

@ast

Increased epidermal growth fac ...... neck squamous cell carcinomas.

@en

Increased epidermal growth fac ...... neck squamous cell carcinomas.

@nl

P1433

Q27851397-51F1FFAA-CC74-4F26-B65F-CB41B947AB20

P1476

Q27851397-834E1919-0681-44C5-A497-B12BAECD5D4E

P2093

Q27851397-0C55BC55-CA6E-43F0-AD5F-0560C0D0BFA0

Q27851397-15F93FC1-9AB8-4AB7-959D-0EBCF2F12057

Q27851397-2C05DF9D-30A5-4B72-9ABE-5BADF9B4CF1C

Q27851397-32E24DB2-B096-4E69-A09F-FFE811F869DF

Q27851397-3530DA93-E724-4D47-9B79-25A6A9ED2391

Q27851397-433725A3-B5E2-43BA-9EF5-98E1111FB6D5

Q27851397-4D207EDA-269A-4AC3-9F80-2C8825804D21

Q27851397-62C3CD6B-5A86-4DEB-BCDF-F9F5423CAD62

Q27851397-A15E2C7B-2E52-4A34-8C7E-77EC00AF5376

Q27851397-B4E76C4F-0B74-4A96-BC0A-148CAECE356F

P304

Q27851397-832C23F0-1C52-48D1-822B-386454D1315C

P31

Q27851397-88F25DD3-8636-4ACA-A312-4207C110522E

P3181

Q27851397-EDD63ED0-0AED-40D2-B987-E35E20BAAC46

P356

Q27851397-ECED4569-AADC-4701-87AE-3C9AE11A9F54

P407

Q27851397-4566AC32-4A19-4897-80E2-8F806ED17B29

P433

Q27851397-FF936DBA-BBE0-47AE-A7AE-9A3F1A857929

P478

Q27851397-05C47B0C-CE32-4C1C-A56C-9B62534A7F46

P50

Q27851397-35C0865A-AEA0-4624-AC07-E90C8EE0ED3A

P577

Q27851397-35EBEB40-9CFF-44DC-97CF-D0C20E989BFE

P698

Q27851397-B37C563E-5B84-49B4-9A76-252662E83C05

P3181

P356

JCO.2006.07.2587

P1433

Journal of Clinical Oncology

P1476

Increased epidermal growth fac ...... neck squamous cell carcinomas

@en

P2093

Anthony Cmelak

http://www.w3.org/2001/XMLSchema#string

Barbara A Murphy

http://www.w3.org/2001/XMLSchema#string

Brian B Burkey

http://www.w3.org/2001/XMLSchema#string

Carolyn Jarrett

http://www.w3.org/2001/XMLSchema#string

Christine H Chung

http://www.w3.org/2001/XMLSchema#string

Fred R Hirsch

http://www.w3.org/2001/XMLSchema#string

James Netterville

http://www.w3.org/2001/XMLSchema#string

Jesse Carter

http://www.w3.org/2001/XMLSchema#string

Joel Parker

http://www.w3.org/2001/XMLSchema#string

Kim Ely

http://www.w3.org/2001/XMLSchema#string

P304

4170-4176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1342462

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.2006.07.2587

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16943533

http://www.w3.org/2001/XMLSchema#string